Medicine
Oxacillin 1 g/20 mL powder for injection
Oxacillin 1 g/20 mL powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store dry powder at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Oxacillin
- Brand
- Sold under the generic name
- Strength
- 1 g/20 mL
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials
- Manufacturers
- WockhardtIndiaFresenius Kabi
- Origin register
- US FDA, United States
- Storage
- Store dry powder at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01CF04 Oxacillin
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 July 2017
- Identifiers
- RxCUI 1743547, 1743549DailyMed set ID af2dccac-98c8-488f-a133-6374b3ca8dba, 195c2054-0746-421d-8b20-8c751bdd772bNDC 63323-813, 64679-698Application ANDA206198, ANDA207147
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 carton / 20 mL in 1 vial | 64679-698-01 | WockhardtIndia | 31 July 2017 |
| 10 vial, single-dose in 1 carton / 20 mL in 1 vial, single-dose | 63323-813-20 | Fresenius Kabi | 1 November 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 26 October 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Oxacillin
Clinical summary
Oxacillin is a penicillin-class antibacterial indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Oxacillin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OxacillinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OXACILLIN prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Oxacillin 1 g/20 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.